Table 2 Univariate analysis of patient survival
From: Quantifying causal effects from observed data using quasi-intervention
Characteristic | All patients (n = 169) | Median OS | P value |
|---|---|---|---|
Age, n (%) | Â | Â | 0.204 |
 ≤55 | 43 (25.44) | 28.9 |  |
 >55 | 126 (74.56) | 26.29 |  |
Sex, n (%) | Â | Â | 0.713 |
 Male | 130 (76.92) | 26.77 |  |
 Female | 39 (23.08) | 27.54 |  |
Smoking status, n (%) |  |  | < 0.001 |
 Never | 124 (73.37) | 26.86 |  |
 Ever | 45 (26.63) | 19.51 |  |
Therapy, n (%) | Â | Â | 0.278 |
 Chemotherapy | 152 (89.94) | 27.16 |  |
 Palliative care | 17 (10.06) | 23.21 |  |
Lymphocyte count (109/L), n (%) | Â | Â | 0.539 |
 ≤7.22 | 103 (60.95) | 26.4 |  |
  > 7.22 | 36 (39.05) | 27.13 |  |
Basophil count (109/L), n (%) | Â | Â | Â |
 ≤ 0.01 | 126 (74.56) | 26.3 | 0.333 |
 > 0.01 | 33 (25.44) | 27.79 |  |
NLR, n (%) |  |  | < 0.001 |
 ≤ 5 | 130 (76.92) | 26.48 |  |
  > 5 | 39 (23.08) | 28.39 |  |
KPS score, n (%) |  |  | < 0.001 |
 60 | 11 (6.5) | 19.01 |  |
 70 | 45 (26.63) | 21.17 |  |
 80 | 93 (55.01) | 29.4 |  |
 90 | 20 (11.83) | 32.95 |  |
Histology, n (%) | Â | Â | 0.715 |
 Adenocarcinoma | 73 (43.2) | 26.77 |  |
 Squamous cell carcinoma | 77 (45.56) | 28.19 |  |
 Small cell carcinoma | 17 (10.06) | 22.53 |  |
 Other | 2 (1.18) | 24 |  |
Disease stage | Â | Â | 0.019 |
 I–II | 12 (7.1) | 36.58 |  |
 III–IV | 157 (92.9) | 26.22 |  |